| Schedule of Basic and Diluted Net Loss Per Share Attributable to Common Stockholders |
The following table sets forth the computation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share data): | | | | | | | | | | | | | | | | | | | Year Ended January 31, | | 2026 | | 2025 | | 2024 | | Net loss | $ | (398,030) | | | $ | (181,078) | | | $ | (331,552) | | | Weighted-average shares outstanding used to compute net loss per share attributable to common stockholders, basic and diluted | 97,795,703 | | | 45,271,666 | | | 44,583,919 | | | Net loss per share attributable to common stockholders, basic and diluted | $ | (4.07) | | | $ | (4.00) | | | $ | (7.44) | |
|
| Schedule of Computation of Diluted net Loss Per Share |
The potential shares of common stock that were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented because including them would have been antidilutive are as follows: | | | | | | | | | | | | | | | | | | | As of January 31, | | 2026 | | 2025 | | 2024 | | Redeemable convertible preferred shares | — | | | 146,360,207 | | | 146,360,207 | | | Stock options issued and outstanding | 39,283,485 | | | 40,971,097 | | | 41,769,970 | | | RSUs issued and outstanding | 9,311,201 | | | 4,653,847 | | | 948,938 | | | ESPP | 819,987 | | | — | | | — | | | Warrants to purchase redeemable convertible preferred stock | — | | | 40,160 | | | 40,160 | | | Shares of common stock subject to repurchase | 5,284 | | | 49,761 | | | 133,332 | | | Convertible notes | — | | | 12,946,170 | | | 13,980,833 | | | Total antidilutive securities | 49,419,957 | | | 205,021,242 | | | 203,233,440 | |
|